ClinicalTrials.gg
RecruitingNCT07819448Updated Sep 17, 2026

Aerobic Exercise as an Adjunct Therapy for Depression

An interventional study of Structured Aerobic exercise in Depressive Disorder, sponsored by Manahil Gill. Recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-09-17.

Sponsored by Manahil Gill · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jun 2026, registered Sep 2026).
  • Started Jun 2026; still recruiting 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Study summary

The goal of this study is to compare the reduction in the severity of depression after a duration of 06 weeks between patients receiving conventional therapy (antidepressant; Sertraline) only and those receiving both conventional therapy and a structured aerobic exercise (cycling, brisk walking).

Read the detailed description

This study will compare two groups A and B for 06 weeks to study the reduction in severity of depression.

  • Comparison group (Group-A): In this group participants will receive standard antidepressant treatment such as Sertraline (SSRIs) and psychotherapy (CBT) only. After 06 weeks, patients will again be assessed for their level of depression using the BDI scale.
  • Experimental group (Group-B): In this group participants will undergo structured exercise program in addition to conventional pharmacotherapy and psychotherapy. They will be introduced to aerobic exercises which includes cycling and brisk walking and will undergo three supervised sessions for 35 minutes each, per week for total 06 weeks under supervision of trainee psychiatry.
02

Conditions studied

  • Depressive Disorder

Keywords

  • Depression
  • Aerobic exercise
  • Antidepressant therapy
  • Psychotherapy
  • Beck Depression Inventory (BDI)
03

In context

Depressive Disorder

855 studies on the registry are indexed under Depressive Disorder; 159 are open to participants now.

This study's planned enrollment of 66 is below the median of 88 across 689 interventional studies indexed under Depressive Disorder.

Browse Depressive Disorder studies →

Lead sponsor

This is the only study on the registry with Manahil Gill as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

i. All new patients diagnosed with moderate and severe depression using BDI scale according to ICD-11 criteria between the ages of 18-55 years.

ii. Both genders will be included.

Exclusion criteria

Exclusion Criteria:

i. Patients with severe physical disabilities such as Spinal cord injuries, severe osteoporosis or medical conditions that prevent exercise such as ischemic changes in pre-exercise.

ii. Pregnant females. iii. Individuals already engaging in physical activities like athletes.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ECG (electrocardiogram)

A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
66 participants (estimated)

Study arms

  • No intervention
    Comparison

    Participants will receive conventional treatment only for 06 weeks

  • Experimental
    Aerobic Exercise

    Participants will receive structured aerobic exercise cycling or brisk walking in addition to conventional treatment for 06 weeks

    Behavioral: Structured Aerobic exercise

Interventions

  • BehavioralStructured Aerobic exercise

    Participants will receive structured, supervised aerobic exercise ( cycling, brisk walking), in addition to conventional treatment consisting of 03 sessions per week, 35 minutes each for 06 weeks.

06

What researchers measure

Primary outcomes

  1. Change in Beck Depression Inventory (BDI) score

    The primary outcome will be the mean change in Beck Depression Inventory (BDI) score from baseline to the end of 06 weeks intervention period. It is a 21- item self-report scale with total scores ranging from 0 to 63. Lower scores indicate fewer depressive symptoms and therefore a better outcome. The mean change in BDI score will be compared between the aerobic exercise (plus conventional treatment ) group and the non exercise group. (conventional treatment only).

    Time frame: Baseline to 06 weeks

07

Study locations

1 of 1 sites recruiting
  • CMH Bahawalpur
    Chak Four Hundred Fifty-four, Punjab Province 63100, Pakistan
    Recruiting
    • Manahil Gill, MBBS · Contactmanahilgill143@gmail.com · +92 304 6527981
    • Manahil Gill, MBBS, Registrar Psychiatry · Principal investigator
    • Beenish Hassan Khan, MBBS, FCPS Psychiatry · Principal investigator
    • Mansoor Mustafa, MBBS, FCPS Psychiatry · Principal investigator
08

References and documents

Publications

  • Elgendy H, Shalaby R, Agyapong B, Lesage D, Paulsen L, Delday A, Duiker S, Surood S, Wei Y, Nkire N, Agyapong VIO. Effectiveness of Group Physical Exercise in Treating Major Depressive Disorder: An Analysis of Secondary Data from an Aborted Randomized Trial. Behav Sci (Basel). 2024 Mar 8;14(3):219. doi: 10.3390/bs14030219. PubMed 38540522 ↗
  • Imboden C, Gerber M, Beck J, Holsboer-Trachsler E, Puhse U, Hatzinger M. Aerobic exercise or stretching as add-on to inpatient treatment of depression: Similar antidepressant effects on depressive symptoms and larger effects on working memory for aerobic exercise alone. J Affect Disord. 2020 Nov 1;276:866-876. doi: 10.1016/j.jad.2020.07.052. Epub 2020 Jul 18. PubMed 32739704 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07819448
Lead sponsor
Manahil Gill
Responsible party
Manahil Gill (Registrar Psychiatry, Combined Military Hospital Bahawalpur, Combined Military Hospital Bahawalpur) — Sponsor-investigator
First posted
Sep 15, 2026
Start date
Jun 1, 2026
Primary completion
Feb 1, 2027 (estimated)
Completion
Feb 1, 2027 (estimated)
Last update
Sep 17, 2026

Study contacts

Manahil Gill, MBBS
Contact
manahilgill143@gmail.com
+92 304 6527981
Muhammad Ahsan Mustafa, MBBS
Contact
+ 92 333 3396180

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion